First Trust Indxx MeddevMDEVETF
13F holders, Q3 2024 (September 30)7holders
1new positions
1sold out
$22.25avg. 13F price*
At the end of Q3 2024, 7 institutions reported holding First Trust Indxx Meddev (MDEV) in their 13F filings, unchanged from Q2 2024. 1 opened new positions and 1 sold out. The largest holders were Glenview Trust Co ($821K), Arax Advisory Partners ($622K) and Jane Street Group, LLC ($494K).
- Company
- First Trust Indxx Meddev
- CUSIP
- 33738R639
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $237K |
| Exits | 1 | $9K |
All 13F filers, Q2 2024 → Q3 2024: 22,811 shares bought and 400 shares sold, net +22,411 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 7 holders
| Glenview Trust Co | 0.02% | No change | 36,870 | $821K |
| Arax Advisory Partners | 0.06% | Add +16.9% | 27,957 | $622K |
| Jane Street Group, LLC | 0.00% | Add +50.2% | 22,186 | $494K |
| Susquehanna International Group, LLP | 0.00% | New | 10,630 | $237K |
| Osaic Holdings, Inc. | 0.00% | No change | 1,405 | $31K |
| Harbour Investments, Inc. | 0.00% | No change | 1,302 | $29K |
| UBS Group AG | 0.00% | Add +1147.6% | 786 | $17K |
"% of holder's portfolio" is MDEV's weight in each manager's 13F, not the share of First Trust Indxx Meddev the manager owns.